Glenmark Pharmaceuticals has informed about a press release dated April 29, 2016 informing ‘Glenmark Pharmaceuticals receives tentative ANDA approval for Adapalene and Benzoyl Peroxide Gel, 0.1% / 2.5%’.
The above information is a part of company’s filings submitted to BSE.